OverviewChartNewsTraderScreen

BAVARIAN NORDIC AS/  DK0015998017  /

Vienna Global Market
2024-05-15  9:05:31 AM Chg. +0.24 Volume Bid2:30:05 PM Ask2:30:04 PM High Low
22.70EUR +1.07% 0
Turnover: -		 22.47Bid Size: 412 -Ask Size: - 22.70 22.70
GlobeNewswire 04-29 Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chiku...
GlobeNewswire 04-02 Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire 02-23 Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
GlobeNewswire 2023-11-08 Emergent BioSolutions Reports Third Quarter 2023 Financial Results
TeleTrader 2022-08-19 EU makes monkeypox vaccine more available
TeleTrader 2022-08-18 WH announces new strategies against monkeypox
TeleTrader 2022-07-30 Spain confirms second monkeypox death
TeleTrader 2022-07-29 Spain confirms Europe's first monkeypox death
TeleTrader 2022-07-25 Monkeypox vaccine approved by EU
TeleTrader 2022-07-22 EMA gives preliminary approval to monkeypox jab
GlobeNewswire 2022-03-21 Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire 2022-02-28 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire 2022-02-14 Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire 2021-12-06 Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire 2021-12-05 Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire 2021-09-01 Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire 2021-08-23 Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire 2021-08-23 Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire 2021-08-09 Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
GlobeNewswire 2021-06-11 Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
GlobeNewswire 2021-03-08 Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-i...
GlobeNewswire 2020-12-16 Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
GlobeNewswire 2020-08-24 Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Small...
GlobeNewswire 2020-07-22 Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
GlobeNewswire 2020-07-01 Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine